Transplant and Addiction Project (TAP) - 1

ClinicalTrials.gov ID: NCT00249652

Public ClinicalTrials.gov record NCT00249652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Drug Treatment for Transplant Candidates

Study identification

NCT ID: NCT00249652
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Enrollment: 41 participants

Conditions and interventions

Conditions

Interventions

TAP Behavioral
TAU Other

Behavioral · Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2003
Primary completion: May 31, 2009
Completion: Aug 31, 2009
Last update posted: Apr 13, 2015

2003 – 2009

United States locations

U.S. sites: 3
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
Behavioral Science Research Unit	New York	New York	10025	—
Renal & Islet Transplant, Center for Liver Disease	New York	New York	10032	—
Liver Transplant Program	Richmond	Virginia	23298	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00249652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 13, 2015 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00249652 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →